Skip to content
PubMed This is a summary of 4 peer-reviewed journal articles Updated
Clinical Immunology

Standard of Care and Treatment Approaches

At a Glance

Treatment for ICOSLG deficiency is individualized supportive care, usually including immunoglobulin replacement when antibody levels or vaccine responses are inadequate, prompt infection treatment, and ongoing lung and blood-count monitoring. Stem cell transplant is not established standard care.

Because ICOSLG deficiency is an exceptionally rare condition, there is no single “one-size-fits-all” treatment protocol. Instead, doctors focus on supportive care—replacing what the immune system is missing and protecting the body from infections. Your care should be managed at a specialized center for inborn errors of immunity, where experts can tailor treatments to your specific needs [1][2].

The Foundation: Immunoglobulin Replacement

A key treatment consideration for patients with ICOSLG deficiency and hypogammaglobulinemia is Immunoglobulin Replacement Therapy (IgRT). When your body struggles to make its own protective antibodies, this treatment provides them from healthy donors [1].

  • Delivery Methods: This can be given as an intravenous (IVIG) infusion into a vein, usually every 3 to 4 weeks, or as a subcutaneous (SCIG) infusion under the skin once a week. IVIG can cause systemic reactions like headache and fatigue, while SCIG may cause local site redness but steadier blood levels.
  • The Goal: IgRT may be considered when IgG is low and vaccine responses are inadequate, aiming to reduce the number and severity of respiratory infections like pneumonia, sinusitis, and bronchitis. Dosing and clinical targets are individualized [1].
  • Limitations: While IgRT is excellent at replacing antibodies, it may not fully protect against the viral skin infections (like warts or cold sores) that are a hallmark of this condition, as those require different parts of the immune system to manage [2].

Managing and Preventing Infections

Beyond replacing antibodies, your care team will likely use a “layered” approach to protect your lungs and skin.

Antibiotic Support

  • Infection-Directed Treatment: When you get a bacterial infection, your doctors will select antibiotics using clinical assessment and cultures where appropriate, with duration based on site, organism, and specialist advice.
  • Antibiotic Prophylaxis: If you continue to have frequent infections despite being on IgRT, your doctor might discuss a daily, low-dose antibiotic. This is a case-by-case decision made after reviewing infection burden, airway disease, local resistance, and adverse effects (such as C. difficile risk) [3][4].

Viral and Skin Care

Because of your susceptibility to DNA viruses like HPV and HSV, proactive monitoring is crucial.

  • Specialist Coordination: You may need regular check-ups with a dermatologist or an infectious disease specialist to manage persistent warts or cold sores.
  • Early Intervention: Treating viral outbreaks early is important to prevent them from becoming extensive or difficult to manage [1][2].

A Note on Stem Cell Transplant (HSCT)

In some severe immune deficiencies, a hematopoietic stem cell transplant (HSCT) is used to “reset” the immune system. However, for ICOSLG deficiency, the situation is more complex:

  1. Not a Standard Care: HSCT is not currently an established standard treatment for this specific deficiency [1].
  2. The “Vessel Wall” Problem: Unlike many other immune diseases where the problem is only in the blood cells, ICOSL is also found on the lining of your blood vessels (endothelium). An unresolved biological concern is that a transplant replaces your blood cells, but it does not replace your blood vessel lining, leaving a theoretical risk that some parts of the deficiency might remain [1].
  3. Caution with Extrapolation: While some patients with a similar condition (ICOS deficiency) have had transplants, the outcomes have been mixed, and researchers caution that ICOSLG deficiency should not be treated exactly the same way due to these biological differences [3].

Long-Term Monitoring

Living with a rare deficiency means being vigilant. Your team will individualize your plan, which may include:

  • Trough Levels: Checking your antibody levels right before your next infusion to ensure they stay high enough to protect you.
  • Lung Imaging: CT scans or lung function tests as clinically indicated to ensure your airways remain healthy.
  • Blood Counts: Regular checks of your neutrophil and lymphocyte counts to monitor for any changes or signs of worsening neutropenia [1].

Common questions in this guide

What is the usual treatment for ICOSLG deficiency?
There is no single treatment protocol because ICOSLG deficiency is exceptionally rare. Care is usually individualized at a center specializing in inborn errors of immunity and may include immunoglobulin replacement, infection treatment or prevention, and regular monitoring.
When might I need IVIG or SCIG for ICOSLG deficiency?
Immunoglobulin replacement may be considered when IgG is low and vaccine responses are inadequate, especially when respiratory infections are recurring. IVIG is given into a vein about every 3 to 4 weeks, while SCIG is given under the skin about weekly; the choice and dose depend on your needs.
Will immunoglobulin replacement prevent warts and cold sores?
Not always. It can replace missing antibodies and may reduce bacterial respiratory infections, but it may not fully protect against DNA-virus infections such as HPV-related warts or HSV cold sores, which involve other immune defenses.
When are preventive antibiotics considered?
A doctor may discuss a daily low-dose antibiotic if infections remain frequent despite immunoglobulin replacement. The decision is individualized and considers infection burden, airway disease, local antibiotic resistance, side effects, and C. difficile risk.
Is a stem cell transplant standard treatment for ICOSLG deficiency?
No. Hematopoietic stem cell transplant is not an established standard treatment for this deficiency, partly because ICOSL is also found on blood-vessel lining that a transplant does not replace. Results from transplant in ICOS deficiency have been mixed and cannot be assumed to apply to ICOSLG deficiency.
What monitoring is needed over time?
Monitoring may include immunoglobulin levels before the next infusion, lung imaging or breathing tests when clinically indicated, and repeated neutrophil and lymphocyte counts. Your specialist can adjust the schedule based on infections, treatment response, and blood-count trends.

Get notified when new evidence is published on Late-onset combined immunodeficiency due to ICOSL deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (4)
  1. 1

    Loss of human ICOSL results in combined immunodeficiency.

    Roussel L, Landekic M, Golizeh M, et al.

    The Journal of experimental medicine 2018; (215(12)):3151-3164 doi:10.1084/jem.20180668.

    PMID: 30498080
  2. 2

    ICOSL in host defense at epithelial barriers: lessons from ICOSLG deficiency.

    Roussel L, Vinh DC

    Current opinion in immunology 2021; (72()):21-26 doi:10.1016/j.coi.2021.03.001.

    PMID: 33756276
  3. 3

    14 Years after Discovery: Clinical Follow-up on 15 Patients with Inducible Co-Stimulator Deficiency.

    Schepp J, Chou J, Skrabl-Baumgartner A, et al.

    Frontiers in immunology 2017; (8()):964 doi:10.3389/fimmu.2017.00964.

    PMID: 28861081
  4. 4

    Expanding Clinical Phenotype and Novel Insights into the Pathogenesis of ICOS Deficiency.

    Abolhassani H, El-Sherbiny YM, Arumugakani G, et al.

    Journal of clinical immunology 2020; (40(2)):277-288 doi:10.1007/s10875-019-00735-z.

    PMID: 31858365

This page explains supportive treatment and monitoring for ICOSLG deficiency for informational purposes only and does not constitute medical advice. Your immunology team should tailor infection prevention, immunoglobulin replacement, and any transplant discussion to your situation.